Article
“Hyper-Hypermethylated Status” of the MGMT Gene Promoter Confers Additional Survival Benefits in IDH-Wild-Type Glioblastoma Patients
2021-02-09
Abstract excerpt
<title>Abstract</title> <p>IntroductionMethylation status of the O(6)-Methylguanine-DNA methyltransferase (<italic>MGMT</italic>) promoter plays key role in glioblastoma (GBM) with respect to the patient’s responses to temozolomide chemotherapy and disease prognosis. Although the cut-off value of <italic>MGMT</italic> methylation (≥10%) is currently widely used to dichotomize the<italic> MGMT </italic>status as “...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fc08531-bdcb-567e-b02b-01392e663ecd
- DOI
- 10.21203/rs.3.rs-178009/v1
